GSK PLC header image

GSK PLC

GSK

Equity

ISIN null / Valor 120042705

New York Stock Exchange, Inc (2026-11-04)
USD 51.15+5.03%

GSK PLC
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

GSK PLC is a global healthcare company specializing in pharmaceuticals and vaccines, dedicated to preventing and treating a wide range of diseases. The company operates through key therapeutic areas including respiratory, immunology and inflammation, oncology, as well as HIV and other infectious diseases. Notably, GSK majority-owns ViiV Healthcare, the sole company exclusively focused on HIV treatment and prevention, aiming to end the HIV epidemic. With a robust portfolio of over 20 marketed vaccines, GSK delivers more than one million vaccine doses daily, addressing infectious diseases across all age groups. The company's approach emphasizes early intervention and the use of advanced technologies to support healthcare systems and improve patient outcomes. GSK's commitment to responsible business practices underpins its strategy for long-term growth and trust-building with stakeholders.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

9.25%1Y
48.5%3Y
-4.82%5Y

Performance

25.9%1Y
64.3%3Y
52.2%5Y

Volatility

Market cap

102530 M

Market cap (USD)

Daily traded volume (Shares)

5,281,283

Daily traded volume (Shares)

1 day high/low

34.04 / 33.56

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
3.00
Théo Coupat
Switzerland, 02 Oct 2026
star star star star star
Interesting molecules in their pipeline that are in the later satges of development leading to potential high effects on the stock itself

EQUITIES OF THE SAME SECTOR

Wockhardt Limited
Wockhardt Limited Wockhardt Limited Valor: 1848172
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.68%INR 1,899.80
Ajanta Pharma Limited
Ajanta Pharma Limited Ajanta Pharma Limited Valor: 27480449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.13%INR 3,313.55
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited Apollo Hospitals Enterprise Limited Valor: 11650098
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.58%INR 8,577.00
NATCO Pharma Limited
NATCO Pharma Limited NATCO Pharma Limited Valor: 30461955
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.01%INR 789.60
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.34%INR 582.05
Zydus Lifesciences Limited
Zydus Lifesciences Limited Zydus Lifesciences Limited Valor: 29835501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.95%INR 1,190.00
Dr. Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories Ltd. Dr. Reddy's Laboratories Ltd. Valor: 138953781
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.15%INR 1,372.00
IPCA Laboratories Limited
IPCA Laboratories Limited IPCA Laboratories Limited Valor: 115718957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.27%INR 1,973.15
Jubilant Pharmova Limited
Jubilant Pharmova Limited Jubilant Pharmova Limited Valor: 2477953
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.10%INR 939.45
Trupanion Inc
Trupanion Inc Trupanion Inc Valor: 24738737
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.21%USD 33.67